Search research articles
Contact Us
Filters
Showing results (61-70 of 1,003) with videos related to
Page
of 101
Sort By:
Oncogenesis
|
August 23, 2016
Retinoblastoma-binding protein 2 (RBP2) is frequently expressed in neuroendocrine tumors and promotes the neoplastic phenotype
E C Maggi, J Trillo-Tinoco, A P Struckhoff, et al.
Oncogenesis
|
July 11, 2017
SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
Z Zhang, Y Deng, G Zheng, et al.
Oncogenesis
|
May 16, 2017
Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors
K E Lines, M Stevenson, P Filippakopoulos, et al.
Oncogenesis
|
June 16, 2018
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
Jiwei Guo, Yan Wu, Jing Du, et al.
Oncogenesis
|
April 20, 2023
Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer
Jie Zhou, Guanming Chen, Jiuling Wang, et al.
Oncogenesis
|
April 12, 2023
PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability
Natalia Martínez, Teresa Gragera, María Pilar de Lucas, et al.
Oncogenesis
|
April 14, 2015
RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1
K Ponnusamy, N Kohrs, A Ptasinska, et al.
Oncogenesis
|
March 31, 2015
Rap1 is indispensable for TRF2 function in etoposide-induced DNA damage response in gastric cancer cell line
X Li, W Liu, H Wang, et al.
Oncogenesis
|
August 21, 2020
Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition
Shakti Ranjan Satapathy, Geriolda Topi, Janina Osman, et al.
Oncogenesis
|
May 25, 2023
CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
Mariusz Shrestha, Dong-Yu Wang, Yaacov Ben-David, et al.
Page
of 101
Search research articles
Search
Showing results (61-70 of 1,003) with videos related to
Sort By:
Page
of 101
Oncogenesis
|
August 23, 2016
Retinoblastoma-binding protein 2 (RBP2) is frequently expressed in neuroendocrine tumors and promotes the neoplastic phenotype
E C Maggi, J Trillo-Tinoco, A P Struckhoff, et al.
Oncogenesis
|
July 11, 2017
SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
Z Zhang, Y Deng, G Zheng, et al.
Oncogenesis
|
May 16, 2017
Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors
K E Lines, M Stevenson, P Filippakopoulos, et al.
Oncogenesis
|
June 16, 2018
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
Jiwei Guo, Yan Wu, Jing Du, et al.
Oncogenesis
|
April 20, 2023
Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer
Jie Zhou, Guanming Chen, Jiuling Wang, et al.
Oncogenesis
|
April 12, 2023
PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability
Natalia Martínez, Teresa Gragera, María Pilar de Lucas, et al.
Oncogenesis
|
April 14, 2015
RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1
K Ponnusamy, N Kohrs, A Ptasinska, et al.
Oncogenesis
|
March 31, 2015
Rap1 is indispensable for TRF2 function in etoposide-induced DNA damage response in gastric cancer cell line
X Li, W Liu, H Wang, et al.
Oncogenesis
|
August 21, 2020
Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition
Shakti Ranjan Satapathy, Geriolda Topi, Janina Osman, et al.
Oncogenesis
|
May 25, 2023
CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
Mariusz Shrestha, Dong-Yu Wang, Yaacov Ben-David, et al.
Page
of 101